GlucoTrack Stock Scheduled to Reverse Split on Monday, August 31st (NASDAQ:GCTK)

GlucoTrack, Inc. (NASDAQ:GCTK)’s stock is scheduled to reverse split on the morning of Monday, August 31st. The 1-15 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, August 30th.

GlucoTrack Trading Down 10.9%

Shares of NASDAQ GCTK traded down $0.03 on Thursday, reaching $0.29. 1,670,509 shares of the company traded hands, compared to its average volume of 24,427,032. GlucoTrack has a fifty-two week low of $0.25 and a fifty-two week high of $14.14. The company has a 50 day moving average of $0.39 and a 200 day moving average of $0.75. The company has a current ratio of 0.46, a quick ratio of 0.46 and a debt-to-equity ratio of 0.08.

GlucoTrack (NASDAQ:GCTK) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.76 EPS for the quarter.

Analysts Set New Price Targets

GCTK has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of GlucoTrack from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of GlucoTrack in a research note on Friday, July 17th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, GlucoTrack has an average rating of “Sell”.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in GCTK. Bank of America Corp DE grew its position in GlucoTrack by 102,125.0% in the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares during the last quarter. Boothbay Fund Management LLC acquired a new position in shares of GlucoTrack during the 4th quarter valued at $52,000. Finally, Ikarian Capital LLC acquired a new position in GlucoTrack during the fourth quarter worth about $177,000. 10.92% of the stock is currently owned by institutional investors.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.